Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Medpace Holdings Inc
MEDP | US
410.54
USD17.12
4.35%
MEDP | US
Loading StockChartView...
About Medpace Holdings Inc
Sector
Healthcare
Industry
Diagnostics & Research
Earnings date
30/06/2024
As of date
24/04/2026
Close
410.54
Open
390.01
High
415.97
Low
390.01
Medpace Holdings Inc. provides clinical research-based drug and medical device development services in North America Europe and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical biotechnology and medical device industries; and development plan design coordinated central laboratory project management regulatory affairs clinical monitoring data management and analysis pharmacovigilance new drug application submissions and post-marketing clinical support services. In addition it offers bio-analytical laboratory services clinical human pharmacology imaging services and electrocardiography reading support for clinical trials. Medpace Holdings Inc. was founded in 1992 and is based in Cincinnati Ohio.
View LessMEDP | US
Risk
86.7
Sharpe
0.52
Luna's Score
63/100
Recommendation
Hold
Luna says (MEDP | US)
What's Working
Strength based on increasing price with high volume
High Current Volume and Positive 1-Day Return
Largecap (10B - 200B USD)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Strong Revenue Growth (> 10%)
What's not Working
Price Below SMA10D
High Short-term Volatility
High Market Beta (> 0.8)
Rich in Valuation (Price to Book > 8)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
Loading RiskMeterView...
10 days
116.2%1 month
86.7%3 months
65.2%6 months
50.0%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
33.43
Fwd. PE
26.04
Price to book
13.92
Debt to equity
0.20
Debt to assets
0.08
Ent. to EBITDA
25.03
Ent. to rev.
5.05
PEG
1.58
Other Fundamentals
EBITDA
409.52M
MarketCap
12.73B
MarketCap(USD)
12.73B
Div. yield
-
Op. margin
19.91
Erngs. growth
42.50
Rev. growth
14.60
Ret. on equity
58.86
Short ratio
3.07
Short perc.
6.00
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
157.19
Range1M
157.19
Range3M
235.07
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
2.17
Price X volume
369.49M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 25.03 | 12.67 | Expensive |
| Ent. to Revenue | 5.05 | 44.00 | Cheaper |
| PE Ratio | 33.43 | 40.09 | Par |
| Price to Book | 13.92 | 77.50 | Cheaper |
| Dividend Yield | - | 1.18 | - |
| Std. Deviation (3M) | 65.19 | 59.59 | Par |
| Debt to Equity | 0.20 | -14.36 | Expensive |
| Debt to Assets | 0.08 | 0.34 | Cheaper |
| Market Cap | 12.73B | 13.71B | Par |
